Coreline Soft

Coreline Soft is a medical AI company specializing in thoracic imaging. Our flagship AI platform, AVIEW, supports early detection and structured analysis of three major lung diseases — lung cancer, COPD, and coronary artery disease — through our B3 systems. In addition, we are expanding into advanced tools for interstitial lung disease (ILD), idiopathic pulmonary fibrosis (IPF), and infectious pneumonia, including COVID-19. 🔹 Clinical-validated & nationally adopted · Official AI provider for Korea’s nationwide lung cancer screening program (K-LUCAS) since 2017 — the world’s second national LCS initiative following the U.S. · Selected by NELSON Trial’s 4-ITLR project in the Netherlands, with AVIEW implemented at Erasmus MC, DKFZ Heidelberg, and University Hospital of Essen. · Supporting multiple German university hospitals in a national LCS pilot project launched in 2021. 🔹 Used by top European hospitals Our COPD and CAC solutions are used in hospitals including: · UZ Leuven (Belgium), University of Leicester (UK), University of Parma (Italy) · Recognized for excellence in early detection, phenotyping, and surgical planning. At Coreline, we aim to reshape the future of lung diagnostics — combining AI, imaging, and clinical needs into real-world impact.